Anna Wald

23PUBLICATIONS
108CO-AUTHORS
Major global burdens of diseaseEpidemiological modellingSocial epidemiologyNanotoxicology, health and safetyObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 17, 2026
Efficacy and Safety of Pritelivir vs Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial.

|May 25, 2026
Mathematical modeling of the population-level impact of hypothetical herpes simplex virus type 2 curative therapy.

|Feb 02, 2026
Herpes Simplex Virus Type 2 Screening in Persons with and Without HIV: Evidence, Challenges, and Future Directions.

Laith J Abu-Raddad, Hiam Chemaitelly, Anna Wald

|Oct 16, 2025
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents.

S Tori Ellison, Ian Hayman, Kristy Derr

|Jul 23, 2025
Stability of Spiked Chlamydia Trachomatis and Neisseria Gonorrhea in Urine and Swab Specimens After Prolonged Storage at Room and Freezer Temperatures Using Aptima Combo-2 Test.

Helen Cristina Stankiewicz Karita, Amalia S Magaret, Stacy Selke

|Jan 29, 2025
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials.

Roy F Chemaly, Tali Shafat, Anna Wald

Pageof 4

Frequent Collaborators

6 joint publications

David M Koelle

5 joint publications

Alexander L Greninger

5 joint publications

Christine Johnston

3 joint publications

Keith R Jerome